Related Experiment Videos
Transoral laser surgery for early glottic cancers
Sultan A Pradhan1, Prathamesh S Pai, Siddalingeshwar I Neeli
1Head and Neck Services, Tata Memorial Hospital, Parel, Mumbai, India. npradhan@vsnl.com
Archives of Otolaryngology--Head & Neck Surgery
|June 18, 2003
Summary
Transoral laser surgery is a safe and effective treatment for early glottic cancers, preserving larynx function in most patients. This minimally invasive approach offers excellent oncologic outcomes with high recurrence-free survival rates.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Oncology
Background:
- Early glottic cancers require effective treatment to ensure oncologic safety and preserve laryngeal function.
- Transoral endoscopic laser surgery presents a minimally invasive option for managing these early-stage malignancies.
Purpose of the Study:
- To evaluate the oncologic safety and functional outcomes of transoral laser surgery for early glottic cancers.
- To assess recurrence rates and larynx preservation following this surgical technique.
Main Methods:
- A cohort of 107 patients with early glottic cancers underwent transoral endoscopic laser surgery.
- Patient data included cancer stage (in situ, T1a, T1b, T2, TX) and lesion location.
- Follow-up assessed oncologic outcomes, including local and regional recurrence, and larynx preservation.
Main Results:
- The study included 107 patients with early glottic cancers, with most lesions being infiltrative (80.4%).
- The overall larynx preservation rate was 92.5%, with 94.4% of patients alive and disease-free at a median of 40.7 months.
- Recurrence-free survival was 86.6% at 2 years, decreasing to 78.1% at 10 years.
Conclusions:
- Transoral laser surgery is an oncologically safe treatment modality for early glottic cancers.
- This minimally invasive approach effectively preserves laryngeal function while achieving favorable oncologic control.